NCT00006387View on ClinicalTrials.gov

Vaccine Therapy Plus QS21 in Treating Patients With Advanced Pancreatic or Colorectal Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

October 31, 2000

Primary Completion Date

January 31, 2002

Study Completion Date

January 31, 2002

Conditions
Colorectal CancerPancreatic Cancer
Interventions
BIOLOGICAL

QS21

BIOLOGICAL

ras peptide cancer vaccine

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Fox Chase Cancer Center

OTHER

NCT00006387 - Vaccine Therapy Plus QS21 in Treating Patients With Advanced Pancreatic or Colorectal Cancer | Biotech Hunter | Biotech Hunter